Financial Ratios

ADLINE CHEM LAB LTD.

NSE : NABSE : 524604ISIN CODE : INE276T01018Industry : Pharmaceuticals & DrugsHouse : Private
BSE27.270 (0 %)
PREV CLOSE ( ) 27.27
OPEN PRICE ( ) 27.27
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 200
TODAY'S LOW / HIGH ( )27.27 27.27
52 WK LOW / HIGH ( ) 5.428.97
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-7.241.23-2.19-6.440.05
   CEPS(Rs)-7.091.83-0.44-5.711.30
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-2.684.533.305.494.63
   Tax Rate(%)0.00-6.820.00-7.338.96
Margin Ratios
   Core EBITDA Margin(%)-40.21-3.71-50.549.81
   EBIT Margin(%)92.22-19.76-52.911.84
   Pre Tax Margin(%)91.22-20.28-53.210.54
   PAT Margin (%)97.44-20.28-57.110.49
   Cash Profit Margin (%)144.97-4.11-50.7013.62
Performance Ratios
   ROA(%)-171.5513.66-19.42-25.580.12
   ROE(%)-783.4531.35-49.89-127.091.02
   ROCE(%)-226.9816.18-23.82-49.360.93
   Asset Turnover(x)0.000.140.960.450.25
   Sales/Fixed Asset(x)0.131.060.510.29
   Working Capital/Sales(x)0.00-0.49-4.81-5.26-0.62
Efficiency Ratios
   Fixed Capital/Sales(x)7.610.941.953.45
   Receivable days409.8286.9197.25142.24
   Inventory Days161.3242.79119.89180.36
   Payable days259.8747.7184.29320.16
Valuation Parameters
   PER(x)0.005.350.000.00148.31
   PCE(x)-0.763.59-11.48-0.955.37
   Price/Book(x)-2.021.451.550.991.51
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)6.930.890.911.66
   EV/Core EBITDA(x)22.32-45.65-24.76-1.8111.08
   EV/EBIT(x)-1.057.52-4.51-1.7189.97
   EV/CE(x)71.761.051.000.790.42
   M Cap / Sales5.210.470.480.73
Growth Ratio
   Net Sales Growth(%)-100.00-88.36-3.9917.82-30.90
   Core EBITDA Growth(%)277.3950.9093.11-494.98-22.44
   EBIT Growth(%)-723.26154.3264.14-3482.02-70.60
   PAT Growth(%)-689.86155.9365.910.001432.63
   EPS Growth(%)-689.88155.9365.910.001431.28
Financial Stability Ratios
   Total Debt/Equity(x)-0.850.501.300.891.97
   Current Ratio(x)0.050.220.600.690.38
   Quick Ratio(x)0.050.090.480.420.16
   Interest Cover(x)92.20-38.23-172.431.42
   Total Debt/Mcap(x)0.420.340.840.901.31

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.